Title: Failure of tofacitinib of achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations
Authors: Wong, J
Wall, M
Corboy, GP
Taubenheim, N
Gregory, GP
Opat, S
Shortt, J
Issue Year: 2020
Publisher COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
Series COLD SPRING HARBOR MOLECULAR CASE STUDIES:
Abstract Author summary Annual influenza infections cause significant morbidity and morbidity globally. Established T-cell immunity directed at conserved viral regions provides some protection against influenza viruses and promotes rapid recovery, leading to better clinical outcomes. Killer CD8(+)T-cells recognising viral peptides in a context of HLA-I glycoproteins, provide the broadest ever reported immunity across distinct influenza strains and subtypes. We asked whether the expression of certain HLA-I alleles affects CD8(+)T cells responses. Our study clearly illustrates altered immunodominance hierarchies and immunodomination within broadly-cross-reactive influenza-specific CD8(+)T-cells in individuals expressing two or more universal HLA-I alleles, key for T cell-directed vaccines and immunotherapies. Seasonal influenza virus infections cause 290,000-650,000 deaths annually and severe morbidity in 3-5 million people. CD8(+)T-cell responses towards virus-derived peptide/human leukocyte antigen (HLA) complexes provide the broadest cross-reactive immunity against human influenza viruses. Several universally-conserved CD8(+)T-cell specificities that elicit prominent responses against human influenza A viruses (IAVs) have been identified. These include HLA-A*02:01-M1(58-66)(A2/M1(58)), HLA-A*03:01-NP265-273, HLA-B*08:01-NP225-233, HLA-B*18:01-NP219-226, HLA-B*27:05-NP(383-391)and HLA-B*57:01-NP199-207. The immunodominance hierarchies across these universal CD8(+)T-cell epitopes were however unknown. Here, we probed immunodominance status of influenza-specific universal CD8(+)T-cells in HLA-I heterozygote individuals expressing two or more universal HLAs for IAV. We found that while CD8(+)T-cell responses directed towards A2/M1(58)were generally immunodominant, A2/M1(58)(+)CD8(+)T-cells were markedly diminished (subdominant) in HLA-A*02:01/B*27:05-expressing donors followingex vivoandin vitroanalyses. A2/M1(58)(+)CD8(+)T-cells in non-HLA-B*27:05 individuals were immunodominant, contained optimal public TRBV19/TRAV27 TCR alpha beta clonotypes and displayed highly polyfunctional and proliferative capacity, while A2/M1(58)(+)CD8(+)T cells in HLA-B*27:05-expressing donors were subdominant, with largely distinct TCR alpha beta clonotypes and consequently markedly reduced avidity, proliferative and polyfunctional efficacy. Our data illustrate altered immunodominance patterns and immunodomination within human influenza-specific CD8(+)T-cells. Accordingly, our work highlights the importance of understanding immunodominance hierarchies within individual donors across a spectrum of prominent virus-specific CD8(+)T-cell specificities prior to designing T cell-directed vaccines and immunotherapies, for influenza and other infectious diseases.
URI: https://publications.svi.edu.au/publications/7089
Other Identifiers 10.1101/mcs.a004994
Publication type Article